Trial intelligence / Profile preview

Continuous wound infiltration after hallux valgus surgery

2013-005106-64Phase 4Completed

Sponsor
Medical University of Innsbruck
Start
Mar 2014
Modality
Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
Countries
1
01

Overview

Phase 4 trial of ropivacaine in bunion deformity (HAV) (2 arms), sponsored by Medical University of Innsbruck. Primary endpoints: Average pain intensity and Peak pain intensity. Started Mar 2014; status: completed.

02

Drugs

ropivacaine
03

Conditions

bunion deformity (HAV)

Beyond the preview

Go deeper on 2013-005106-64.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2013-005106-64.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call